BRIEF published on 03/03/2026 at 22:35, 4 months 26 days ago DBV Technologies: February 2026 Voting Rights and Shares Update Voting Rights Shares DBV Technologies NYSE Euronext Paris February 2026
PRESS RELEASE published on 03/03/2026 at 22:30, 4 months 26 days ago Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 Important update on total voting rights and shares as of February 28, 2026 for NYSE Euronext Paris. Total gross voting rights: 278,352,082 Shares Total Voting Rights Regulations NYSE Euronext Paris February 28 2026
BRIEF published on 03/02/2026 at 15:53, 4 months 27 days ago JP Morgan's investment in DBV Technologies reaches new thresholds Crossing Thresholds Equity Swaps Shares And Voting Rights DBV Technologies JP Morgan
BRIEF published on 02/28/2026 at 20:30, 5 months 1 day ago DBV Technologies Unveils Promising Phase 3 VITESSE Study Results at AAAAI 2026 DBV Technologies Phase 3 Results Viaskin Peanut Patch Peanut Allergy Treatment VITESSE Study
BRIEF published on 02/28/2026 at 20:30, 5 months 1 day ago DBV Technologies reveals promising new results for VIASKIN Peanut Clinical Study Immunotherapy DBV Technologies Food Allergies Viaskin Peanut
PRESS RELEASE published on 02/28/2026 at 20:25, 5 months 1 day ago DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting DBV Technologies presents successful Phase 3 VITESSE study data at AAAAI Annual Meeting, highlighting VIASKIN Peanut Patch efficacy in treating peanut-allergic children DBV Technologies Food Allergies Viaskin Peanut Patch Phase 3 VITESSE Study AAAAI Annual Meeting
BRIEF published on 02/09/2026 at 22:35, 5 months 20 days ago DBV Technologies at the Emerging Outlook: Biotech Summit conference Immunotherapy DBV Technologies Viaskin Food Allergies Biotech Summit
BRIEF published on 02/09/2026 at 22:35, 5 months 20 days ago DBV Technologies to Join Guggenheim Biotech Summit Biopharmaceutical DBV Technologies Food Allergies VIASKIN® Patch Guggenheim Securities Summit
PRESS RELEASE published on 02/09/2026 at 22:30, 5 months 20 days ago DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit DBV Technologies to participate in Guggenheim Securities Biotech Summit with CEO Daniel Tassé presenting at the fireside chat on February 12, 2026. Company focusing on food allergy treatment Guggenheim Securities DBV Technologies Food Allergies VIASKIN Patch Biotech Summit
BRIEF published on 02/06/2026 at 09:59, 5 months 24 days ago Janus Henderson crosses 5% threshold in DBV Technologies Euronext Paris Actions Janus Henderson Threshold Crossing DBV Technologies
Published on 07/30/2026 at 13:00, 39 minutes ago Sun Peak Metals Advances Multi-Project Exploration Program in Saudi Arabia - Drill Programs Complete on First Two Projects, Assays Pending
Published on 07/30/2026 at 13:00, 39 minutes ago CoTec Holdings Corp. Investment MagIron Strengthens Leadership Team and Liquidity Position
Published on 07/30/2026 at 13:00, 39 minutes ago Temas and SAGA Successfully Validate RCL Technology With Titanium Recoveries of Up to 90.8% and Vanadium Recoveries of 97.4%
Published on 07/30/2026 at 13:00, 39 minutes ago Electrovaya Launches ElvaPulse(TM) 1500 High-Power Energy Storage Platform for Data Center and Mission-Critical Power Applications
Published on 07/30/2026 at 04:10, 9 hours 29 minutes ago Pathfinder Ventures Announces Appointment of Mark Roseborough as Chief Executive Officer
Published on 07/30/2026 at 13:04, 35 minutes ago Reply S.p.A: The Board of Directors approves the half-year financial report as of 30 June 2026
Published on 07/30/2026 at 12:45, 54 minutes ago H&K AG: Significant growth in revenue, total operating performance and EBITDA; full-year guidance raised
Published on 07/30/2026 at 12:45, 54 minutes ago EQS-Adhoc: H&K AG: Significant growth in revenue, total operating performance and EBITDA; full-year guidance raised
Published on 07/30/2026 at 12:37, 1 hour 2 minutes ago Zentra Group plc: One Victoria - Contractor Administration and Termination
Published on 07/30/2026 at 09:07, 4 hours 32 minutes ago CNP Assicura, a subsidiary of CNP Assurances in Italy, announces an exclusive partnership with Fineco bank in the life insurance segment
Published on 07/30/2026 at 07:30, 6 hours 9 minutes ago Availability of the 2026 Interim Financial Report
Published on 07/30/2026 at 07:30, 6 hours 9 minutes ago Half-year 2026: Accor shows its agility in a challenging global environment
Published on 07/30/2026 at 07:00, 6 hours 39 minutes ago Mersen 2026 guidance raised after strong momentum in the first half
